Equipped with $160M series A, Alveus debuts into crowded obesity development landscape | Fierce Biotech
Litigation, Intellectual Property News
... trial, citing “portfolio considerations. ... The move may help form a bulwark against potential future patent litigation as Roche advances its obesity ...
